Target Name: CYP2A7
NCBI ID: G1549
Review Report on CYP2A7 Target / Biomarker Content of Review Report on CYP2A7 Target / Biomarker
CYP2A7
Other Name(s): CPAD | cytochrome P450, family 2, subfamily A, polypeptide 7 | CYP2A7 variant 1 | Cytochrome P450 2A7 (isoform 1) | CPA7 | CYP2A | Cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 7 | Cytochrome P450, family 2, subfamily A, polypeptide 7 | Cytochrome P450 2A7 | P450-IIA4 | cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 7 | cytochrome P450IIA4 | Cytochrome P450 2A7 (CYP2A7) | CP2A7_HUMAN | CYPIIA7 | cytochrome P450 family 2 subfamily A member 7 | Cytochrome P450 IIA4 | cytochrome P450 IIA4 | Cytochrome P450 family 2 subfamily A member 7, transcript variant 1

Understanding The Role of CYP2A7 in Drug Metabolism and Transport

CYP2A7 (CPAD), a member of the CYP2A family of drugs, is a widely expressed gene that is involved in many physiological processes in the body. One of the most well-known functions of CYP2A7 is its role in drug metabolism and transport. This gene has also been implicated in various diseases, including cancer, cardiovascular disease, and neurodegenerative disorders.

The CYP2A7 gene is located on chromosome 11 and has 11 exons. It is a member of the CYP2A family, which is characterized by the presence of a single transmembrane domain and a cytoplasmic tail. CYP2A7 is a widely expressed gene, with high levels of expression in most tissues and cells of the body.

One of the well-known functions of CYP2A7 is its role in drug metabolism and transport. CYP2A7 is a major gene in the liver, and it is involved in the metabolism of many drugs, including many statins, antidepressants, and benzodiazepines. CYP2A7 encodes a protein that is involved in the production of these drugs, as well as other compounds that are metabolized by the liver.

In addition to its role in drug metabolism, CYP2A7 is also involved in the transport of many different compounds across the cell membrane. This includes proteins that are involved in uptake and transport of drugs, as well as other molecules that are involved in the transport of nutrients and waste products out of the cell.

The CYP2A7 gene has also been implicated in various diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. For example, studies have suggested that individuals with certain genetic variations in the CYP2A7 gene may be at increased risk of developing certain types of cancer. Additionally, there is evidence to suggest that individuals with certain genetic variations in the CYP2A7 gene may be at increased risk of developing cardiovascular disease and neurodegenerative disorders.

In conclusion, CYP2A7 is a widely expressed gene that is involved in many physiological processes in the body. Its role in drug metabolism and transport, as well as its involvement in various diseases, make it an attractive target for research and development. Further studies are needed to fully understand the functions and potential uses of CYP2A7, and to determine its role in the development and treatment of various diseases.

Protein Name: Cytochrome P450 Family 2 Subfamily A Member 7

Functions: Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics

The "CYP2A7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYP2A7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CYP2A7P1 | CYP2B6 | CYP2B7P | CYP2C18 | CYP2C19 | CYP2C61P | CYP2C8 | CYP2C9 | CYP2D6 | CYP2D7 | CYP2D8P | CYP2E1 | CYP2F1 | CYP2F2P | CYP2G1P | CYP2J2 | CYP2R1 | CYP2S1 | CYP2T1P | CYP2U1 | CYP2U1-AS1 | CYP2W1 | CYP39A1 | CYP3A4 | CYP3A43 | CYP3A5 | CYP3A51P | CYP3A7 | CYP3A7-CYP3A51P | CYP3AP2 | CYP46A1 | CYP4A11 | CYP4A22 | CYP4B1 | CYP4F11 | CYP4F12 | CYP4F2 | CYP4F22 | CYP4F26P | CYP4F29P | CYP4F3 | CYP4F30P | CYP4F34P | CYP4F35P | CYP4F59P | CYP4F62P | CYP4F8 | CYP4V2 | CYP4X1 | CYP4Z1 | CYP4Z2P | CYP51A1 | CYP51A1-AS1 | CYP51A1P1 | CYP51A1P2 | CYP51A1P3 | CYP7A1 | CYP7B1 | CYP8B1 | CYREN | CYRIA | CYRIB | CYS1 | CYSLTR1 | CYSLTR2 | CYSRT1 | Cysteine Protease | CYSTM1 | CYTB | CYTH1 | CYTH2 | CYTH3 | CYTH4 | CYTIP | CYTL1 | Cytochrome b5 reductase | Cytochrome bc1 complex | Cytochrome c oxidase | Cytochrome P450 1A (CYP1A) | Cytochrome P450 26 | Cytochrome P450 3A (CYP3A) | Cytochrome P450 4A | Cytochrome P450 Enzymes | Cytohesin | Cytoplasmatic dynein | Cytoplasmic dynein complex | CYTOR | CYYR1 | CYYR1-AS1 | CZIB | D21S2088E | D2HGDH | DAAM1 | DAAM2 | DAAM2-AS1 | DAB1 | DAB1-AS1 | DAB2 | DAB2IP | DACH1